We are proud to welcome Vifor Pharma as the newest member of the Rare Disease Action Forum. We look forward to Vifor’s contribution to the collaborative efforts at the RDAF multi-stakeholder platform which consists of members from industry, patient organizations, healthcare professionals, and research organizations. Together we will continue our efforts to diagnosis, treatment and care for patients with rare diseases in Switzerland.
The RDAF publishes its newsletter
The newsletter, which is published twice a year, gives an overview of all the Rare Disease Action Forum (RDAF) activities during the past half year to raise awareness about rare diseases in Switzerland and improve patient’s access to diagnosis, treatment and care....